Details of the Drug

General Information of Drug (ID: DMBLASN)

• Drug Name: DCVax-Ovarian
• Synonyms: DCVax-L; Dendritic cell-based immunotherapy (ovarian cancer), Northwest Biotherapeutics

Indication

Disease Entry	ICD 11	Status	REF
Brain cancer	2A00	Phase 3	[1]
Pain	MG30-MG3Z	Phase 3	[2]
Recurrent glioblastoma	2A00.00	Phase 3	[3]
Ovarian cancer	2C73	Phase 1	[4]

• Cross-matching ID:
  DrugBank ID: DB17580
  TTD ID: D02XEI
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [2] ClinicalTrials.gov (NCT00045968) Study of a Drug [DCVax-L] to Treat Newly Diagnosed GBM Brain Cancer. U.S. National Institutes of Health.
• [3] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [4] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)